Stock LCTX LINEAGE CELL THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Lineage Cell Therapeutics, Inc.

Equities

LCTX

US53566P1093

Market Closed - Nyse
Other stock markets
 01:00:00 2024-07-03 pm EDT 		5-day change 1st Jan Change
0.9185 USD -1.46% Intraday chart for Lineage Cell Therapeutics, Inc. +2.06% -15.73%
Jul. 02 Lineage Cell Therapeutics Included in Russell 3000 Index MT
May. 21 Lineage Cell Therapeutics, Inc. Announces Updates to 2nd Annual Spinal Cord Injury Investor Symposium CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Baird Starts Lineage Cell Therapeutics at Outperform With $5 Price Target
MT
B. Riley Initiates Lineage Cell Therapeutics at Buy with $4 Price Target, Says Platform, Pipeline Currently Undervalued
MT
LINEAGE CELL THERAPEUTICS : Noble Capital Initiates Coverage on Lineage Cell Therapeutics With Outperform Rating, $8 Price Target
MT
LINEAGE CELL THERAPEUTICS : Chardan Suspends Coverage on Lineage Cell Therapeutics at Buy Rating With $4 Price Target
MT
LINEAGE CELL THERAPEUTICS : Cantor Fitzgerald Starts Lineage Cell Therapeutics at Overweight With $6 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LCTX Stock
  4. News Lineage Cell Therapeutics, Inc.
  5. Analyst Reco.